Investire (@Investiri) profile picture

QGARP Investire | Quality. Growth. Allocation. Resilience. Predictability.

Globally Mobile
Joined October 2021
Photo by Investire (@Investiri)Photo by Investire (@Investiri)Photo by Investire (@Investiri)Photo by Investire (@Investiri)Photo by Investire (@Investiri)Photo by Investire (@Investiri)Photo by Investire (@Investiri)Photo by Investire (@Investiri)Photo by Investire (@Investiri)Photo by Investire (@Investiri)
Free Cash Flow drives shareholder value. Key metrics to watch: 1. FCF Margin >25% 2. FCF ROC >20% 3. FCF/share growth >15% 4. FCF Conversion >85%, 100%+ ideal 5. FCF Yield >10-year Treasury Yield, 3.5%+ ideal #FCF #QGARP
2
1
1
7
3,769
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ $CHEMM thesis in one chart: $CHEMM
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ ChemoMetec $CHEMM thesis in one chart: $CHEMM
1
50
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ ChemoMetec $CHEMM thesis in one chart: $CHEMM
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ BlackRock’s voting stake in ChemoMetec remains at 15.08%, following a shift to 100% direct share voting rights on 26 Oct. Its position through financial instruments fell to 0%. The aggregate voting position is unchanged. $CHEMM
1
1
133
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ BlackRock’s voting stake in ChemoMetec remains at 15.08%, following a shift to 100% direct share voting rights on 26 Oct. Its position through financial instruments fell to 0%. The aggregate voting position is unchanged. $CHEMM
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ Over the last 10 years, ChemoMetec has compounded its FCF at an exceptional CAGR of 44.29%. When paired with a FCF linearity score of 0.91, this performance demonstrates consistency,highly predictable cash generation & a high quality business. $CHEMM
1
1
194
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ Over the last 10 years, ChemoMetec has compounded its FCF at an exceptional CAGR of 44.29%. When paired with a FCF linearity score of 0.91, this performance demonstrates consistency,highly predictable cash generation & a high quality business. $CHEMM
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ BlackRock has reduced its direct voting rights in $CHEMM to 14.97%, falling below the 15% threshold. However, with an increase in financial instruments (0.11%), its aggregate voting position remains unchanged at 15.08%. $CHEMM
1
2
279
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ BlackRock has reduced its direct voting rights in $CHEMM to 14.97%, falling below the 15% threshold. However, with an increase in financial instruments (0.11%), its aggregate voting position remains unchanged at 15.08%. $CHEMM
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ $CHEMM will release Q1 2026/27 results on Nov 5, followed by an investor call on Nov 6. Meanwhile, SEB raised its stock target price to DKK 580 (up from DKK 500) but maintained its Hold rating. $CHEMM
1
2
337
Great businesses - grow profitably, - earn high returns on capital, - convert those gains efficiently into free cash flow, and - sustain all over decades.
A great business is not automatically a fortress business. The distinction is important. #QGARP
2
66
FinXers, here is another valuable piece of wisdom that .@long_equity shared with us πŸ‘‡
There are three great opportunities in quality growth investing. 1. Low revenue growth companies with the potential for high FCF growth through significant margin expansion. E.g. $ICE $BR 2. High return on capital companies with the potential for high FCF growth through buybacks. $MSCI $FTNT $KLAC $LRCX 3. High FCF growth companies with the potential for a significant contraction in FCF yield (in other words, a re-rating). $MSCI $BR I aim to have a portfolio where all three are in play.
2
75
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ $CHEMM will release Q1 2026/27 results on Nov 5, followed by an investor call on Nov 6. Meanwhile, SEB raised its stock target price to DKK 580 (up from DKK 500) but maintained its Hold rating. $CHEMM
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ $CHEMM has launched a DKK100M share buyback program running from Oct. 12, 2026, to March 5,2027. Managed by Danske Bank, the facility covers up to 500K shares, representing 2.9% of the share capital, to optimize the company's capital structure⬇️ $CHEMM
1
2
309
QGARP assesses quality, growth, allocation, resilience and predictability, then decides whether the valuation offers an acceptable return. #QGARP
Core investment framework and principles visualized: #QGARP
2
3
150
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ $CHEMM has launched a DKK100M share buyback program running from Oct. 12, 2026, to March 5,2027. Managed by Danske Bank, the facility covers up to 500K shares, representing 2.9% of the share capital, to optimize the company's capital structure⬇️ $CHEMM
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ At today's AGM, ChemoMetec shareholders approved an authorization for the Board of Directors to acquire the company's shares, while voting to pass on a dividend for FY 2025/26 to support ongoing capital allocation strategy. ⬇️ $CHEMM
1
3
290
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ At today's AGM, ChemoMetec shareholders approved an authorization for the Board of Directors to acquire the company's shares, while voting to pass on a dividend for FY 2025/26 to support ongoing capital allocation strategy. ⬇️ $CHEMM
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ A quick look at ChemoMetec A/S $CHEMM , core financial profile and business overview via the latest Nasdaq Copenhagen and Morningstar factsheet. $CHEMM
1
2
230
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ A quick look at ChemoMetec A/S $CHEMM , core financial profile and business overview via the latest Nasdaq Copenhagen and Morningstar factsheet. $CHEMM
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ BlackRock has increased its voting stake in ChemoMetec to 15.08% on 29 Sept, crossing the 15% statutory threshold under the Danish Capital Markets Act. It was 13.03% on 28 Aug. $CHEMM
1
2
224
NextVision Stabilized Systems Limited $NXSN secures a US$24M purchase order for cameras & accessories from a client. Deliveries are scheduled to run from January through Q2 2027. The contract remains subject to pending regulatory approvals. Link: investor-relations.nextvisio… $NXSN
NextVision Stabilized Systems Limited NextVision secures US$3.5M purchase order for its cameras and accessories from a customer, with product delivery expected by the end of Q1 2027 Link: investor-relations.nextvisio… $NXSN
3
321
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ BlackRock has increased its voting stake in ChemoMetec to 15.08% on 29 Sept, crossing the 15% statutory threshold under the Danish Capital Markets Act. It was 13.03% on 28 Aug. $CHEMM
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ ChemoMetec raised its financial guidance for fiscal year 2027 regarding revenue and EBITDA Link: investor.chemometec.com/news… $CHEMM
1
3
315
NextVision Stabilized Systems Limited NextVision secures US$3.5M purchase order for its cameras and accessories from a customer, with product delivery expected by the end of Q1 2027 Link: investor-relations.nextvisio… $NXSN
1
2
593
NextVision Stabilized Systems Limited Fidelity sells 5.7M shares of drone camera maker NextVision for $426M via Goldman Sachs, per Calcalistech - CTECH Link: calcalistech.com/ctechnews/a… $NXSN
NextVision $NXSN announced on Sept. 09, 2026, that it received regulatory approvals for a $2.7M purchase order. This clearance fulfills one of the pending orders from a previous company report filed on August 7, 2026 requiring specific regulatory no objection. $NXSN
1
2
575
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ ChemoMetec raised its financial guidance for fiscal year 2027 regarding revenue and EBITDA Link: investor.chemometec.com/news… $CHEMM
ChemoMetec A/S πŸ‡©πŸ‡°πŸ”¬πŸ§ͺπŸ‘©β€πŸ”¬πŸ§¬ Completion of share buyback programmeπŸ‘‡ $CHEMM
1
2
308